Press Releases Gritstone bio, Inc.

Equities

GRTS

US39868T1051

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
0.8061 ^USD	-0.90%		+8.13%	-60.49%

01:00pm	Gritstone Bio, Inc. Announces Board Changes	CI
Apr. 15	Nature Medicine Publishes Interim Results from Gritstone Bio's Phase 1/2 Study of "Off-The-Shelf" Neoantigen Vaccine Platform	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Gritstone bio Announces Appointment of Stephen Webster to its Board of Directors	07:01am	AQ
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTS	Apr. 20	PR
Nature Medicine Publishes Interim Results from Gritstone bio's Phase 1/2 Study of 'Off-the-Shelf' Neoantigen Vaccine Platform	Apr. 16	AQ
Nature Medicine Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE)	Apr. 15	AQ
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTS	Apr. 12	PR
Gritstone bio to Participate in Upcoming Investor and Scientific Conferences	Apr. 08	AQ
Gritstone bio Presents Improvements to EDGE™ Platform at AACR 2024	Apr. 08	AQ
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTS	Apr. 04	PR
Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering	Apr. 01	AQ
Gritstone bio Announces Proposed Public Offering	Apr. 01	AQ
Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)	Apr. 01	AQ
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTS	Mar. 19	PR
Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates	Mar. 05	AQ
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTS	Mar. 04	PR
Gritstone bio Announces Workforce Reduction	Feb. 29	AQ
Gritstone bio to Participate in Upcoming Investor and Scientific Conferences	Feb. 21	AQ
Gritstone bio Announces Update to Comparative Phase 2b COVID-19 Clinical Trial	Feb. 12	AQ
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Feb. 08	AQ
Gritstone bio to Participate in Upcoming Investor Conference	Jan. 17	AQ
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Jan. 10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Gritstone bio, Inc.

Equities

GRTS

US39868T1051

Press Releases

Filters